NMPA accepts Overland ADCT BioPharma’s BLA for ZYNLONTA
Overland ADCT BioPharma is a joint venture between Overland Pharmaceuticals and ADC Therapeutics. This therapy is seeking an indication to treat adults with relapsed or refractory (r/r) diffuse